Cue Biopharma, Inc. (CUE)
23.18
-0.80
(-3.34%)
USD |
NASDAQ |
Aug 24, 16:00
23.16
-0.02
(-0.09%)
After-Hours: 20:00
Cue Biopharma Max Drawdown (5Y) : 99.01% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.01% |
| June 30, 2026 | 99.01% |
| May 31, 2026 | 99.01% |
| April 30, 2026 | 99.01% |
| March 31, 2026 | 98.73% |
| February 28, 2026 | 98.65% |
| January 31, 2026 | 98.65% |
| December 31, 2025 | 98.65% |
| November 30, 2025 | 98.52% |
| October 31, 2025 | 98.52% |
| September 30, 2025 | 98.52% |
| August 31, 2025 | 98.52% |
| July 31, 2025 | 98.52% |
| June 30, 2025 | 98.52% |
| May 31, 2025 | 98.52% |
| April 30, 2025 | 98.52% |
| March 31, 2025 | 98.52% |
| February 28, 2025 | 98.52% |
| January 31, 2025 | 98.52% |
| December 31, 2024 | 98.52% |
| November 30, 2024 | 98.52% |
| October 31, 2024 | 98.52% |
| September 30, 2024 | 98.52% |
| August 31, 2024 | 98.07% |
| July 31, 2024 | 97.90% |
| Date | Value |
|---|---|
| June 30, 2024 | 95.96% |
| May 31, 2024 | 95.56% |
| April 30, 2024 | 95.56% |
| March 31, 2024 | 94.40% |
| February 29, 2024 | 94.40% |
| January 31, 2024 | 94.40% |
| December 31, 2023 | 94.40% |
| November 30, 2023 | 94.40% |
| October 31, 2023 | 94.40% |
| September 30, 2023 | 92.74% |
| August 31, 2023 | 92.74% |
| July 31, 2023 | 92.74% |
| June 30, 2023 | 92.74% |
| May 31, 2023 | 92.74% |
| April 30, 2023 | 92.74% |
| March 31, 2023 | 92.74% |
| February 28, 2023 | 92.74% |
| January 31, 2023 | 92.74% |
| December 31, 2022 | 92.74% |
| November 30, 2022 | 92.74% |
| October 31, 2022 | 92.74% |
| September 30, 2022 | 92.74% |
| August 31, 2022 | 92.03% |
| July 31, 2022 | 92.03% |
| June 30, 2022 | 91.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Fortress Biotech, Inc. | 98.41% |
| Equillium, Inc. | 98.91% |
| Legend Biotech Corp. | 78.24% |
| Nurix Therapeutics, Inc. | 91.53% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -65.24 |
| Beta (5Y) | 2.476 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 158.6% |
| Historical Sharpe Ratio (5Y) | -0.2677 |
| Historical Sortino (5Y) | -1.075 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.24% |